suMMARY To document the clinical features and complications of fulminant hepatic failure in childhood, 31 consecutive cases (of whom only 9 survived) were reviewed. Of 26 children with acute hepatitis (HbSAg-negative), liver function steadily deteriorated in all but 2, and encephalopathy occurred within 3 weeks of the onset of symptoms in all except 3 of them. Eight of these patients survived, as did one of 3 in which this deterioration was caused by paracetamol overdosage. Single cases due to Amanita phalloides and halothane died. Encephalopathy lasted from 2 to 16 days in the survivors, and from one to 20 days in the fatal cases. The severity fluctuated by more than one grade in 9 patients. The outcome was not related to the age or sex of patient, clinical or biochemical abnormalities at presentation, or to the duration of the encephalopathy. Prothrombin time was prolonged by more than 90 seconds in 10 fatal cases, but in none of the survivors. The outcome was related to the severity ofthe encephalopathy, only one (6%) of 19 children in grade 4 coma surviving, and to the occurrence of neurological complications-particularly brain stem dysfunction (9 cases), decerebrate posturing (12 cases), and convulsions (7 cases). Massive gastrointestinal bleeding (14 cases) and renal failure (10 cases) were confined to the fatal group. At necropsy 7 (54%) of 13 had cerebral oedema.
influence on prognosis.4 Treatment incorporates intensive supportive care with a variety of measures undertaken to control homeostasis, prevent alimentary bleeding, and control encephalopathy. The rationale for such treatment is based almost entirely on observations in adult patients. If adults survive the acute illness hepatic recovery is usually complete.5"
In the present study we retrospectively reviewed clinical, biochemical, and pathological features in 31 children with fulminant hepatic failure of whom 9 survived. We wished to document the clinical syndrome and its complications in childhood, to ascertain differences from the syndrome in adults, and to identify features of prognostic importance at the onset or early in the course of the illness. 252
Patients and methods 31 children reviewed had fulminant hepatic failure as defined by Trey and Davidson7-namely, hepatic encephalopathy within 8 weeks of the onset of symptoms of liver disease in patients in whom hepatic function before the illness was 4 The presumed cause of the hepatic necrosis was acute viral hepatitis (hepatitis B surface antigen negative) in 26 cases, but in only 4 Features of encephalopathy. The duration of the encephalopathy varied from less than one to 22 days (mean 8 -4) in the fatal cases, and from 2 to 16 days (mean 6 4) in the survivors. In those dying rapidly the encephalopathy was steadily progressive but in 9 instances the severity of the encephalopathy improved by at least one grade before subsequently deteriorating. Two patients with relapsing encephalopathy eventually recovered completely. Decebrate posturing (12 cases) , clinical evidence of brain stem dysfunction (9 cases), and convulsions (7 cases) occurred only in fatal cases. There were no survivors among the patients who required mechanically assisted respiration because of brain stem dysfunction. Only one child survived who had been in grade 4 coma for more than 24 hours, although 2 who were transiently in grade 4 coma also survived. It is noteworthy that no patient at any time in his illness developed papilloedema.
Encephalopathy preceded jaundice by 1 to 2 days in all 3 patients with paracetamol overdose. Two died 5 and 11 days after ingestion, the third survived after 6 days in hepatic coma. Nausea, vomiting, and abdominal tenderness with jaundice occurred within 24 hours of ingesting Amanita phalloides and proceeded to grade 4 coma 48 hours later; she died on day 3. In one patient jaundice with features of hepatocellular necrosis occurred 5 days after the 4th halothane anaesthetic in a 4-month period. This progressed to encephalopathy within 48 hours and to death 5 days later. 17 of the patients seen since 1973 received IV dexamethasone in a dose of4 mg every 6 hours given to lessen cerebral oedema. Four survived as did 5 of 12 patients who, in the early years of the study, received prednisolone in a dose of 1-2 mg/kgwper 24 hours.
Nine patients, who had been in grade 4 coma for longer than 12 hours, received temporary liver support using charcoal haemoperfusion (4 cases), and haemodialysis with a polyacrylonitrile membrane (5 cases). All subsequently died. Three in grade 3 coma treated with haemodialysis using'a polyacrylonitrile membrane 'survived. In no case did 'these measures have an immediate effect on the severity of the encephalopathy.
Laboratory investigations. All patients showed biochemical evidence of severe hepatocellular necrosis with high levels of serum transaminase, bilirubin, and alkaline phosphatase (Table 1) . In those who survived longer than 7 days, transaminase values fell to between one and 8 times the upper limit of normal. 16 of the fatal cases and all 9 survivors had serum albumin levels <35 g/l (<3 5 g/100 ml). All patients had prolongation of the prothrombin time. In 10 fatal cases, the prolongation of the prothrombin time was >90 seconds, none of the survivors having values above this level (P<0 025). Serum bicarbonate levels were frequently abnormal both in fatal cases and survivors. Both low levels and high levels were found at different stages of the illness in nearly every instance. The bicarbonate levels were significantly higher in fatal cases than in the survivors (P<001). The severity of other biochemical abnormalities was similar in the two groups (Table 2) . Despite IV glucose infusion, 9 Conversion-SI to traditional units-Ca: 1 1imo1/l / 4 mgilOO ml.
P04: 1 &mol/1 * 3.1 mg/100 ml.
Renal failure occurred in 10 fatal cases. In 2 there was clinical, biochemical, and necropsy evidence of acute tubular necrosis. Two had the urinary features of functional renal failure9 and normal renal histology at necropsy. In the remaining patients the data were insufficient to define the type of renal failure. Nine of 13 who developed ascites survived.
Septicaemia occurred in 5 patients, the organisms being Staphylococcus aureus, Pseudomonaspyocyanea, Candida albicans, group D streptococci, and Staphylococcus albus. Four patients had infections of the urinary tract. Candida sp. was the major cause of infection in one patient who survived and in 2 fatal cases. In one of these there was severe depression both of erythropoiesis and granulocytes. One patient with complete pancytopenia required red blood cell and granulocyte transfusion before making a complete recovery. Two patients had severe persistent thrombocytopenia with platelet counts <10 x 109/l.
Nine developed lobar collapse, one developed bilateral pleural effusion, and a further child developed a lung abscess. In 3 patients the temperature fell to <350C without evident cause.
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Necropsy findings. Percutaneous liver biopsies obtained immediately after death in 11 patients showed severe hepatocellular necrosis as evidenced by extensive collapse of the reticulin framework, with cellular infiltrate within the portal tracts and in necrotic areas. The amount of cellular infiltrate increased with the duration of the liver disease. There was prominent bile duct reduplication in and around the portal tracts, with disruption of the limiting plates. There were no features ofcirrhosis.
Necropsy examinations were performed in 13 cases. The liver weight ranged from 10 to 90% of the average weight for the patient's age10 except in one infant in whom the liver weighed 2j times normal.
The liver histology in this patient was similar to that in others, except that reticulo-endothelial cell reaction was particularly pronounced. In the remaining cases the histological appearances were similar to those seen in the needle specimens. In 2 patients, there was histological evidence of renal tubular necrosis. One patient had haemorrhagic pancreatitis.
Cerebral oedema was present in 7 patients, 4 showing cerebellar or medullary herniation. Follow-up of survivors. The duration of follow-up was between 4 and 77 months (mean 34). Time in hospital was between 5 and 13 weeks, but all children returned to normal activities within 4 weeks of discharge from hospital and have remained well subsequently. Height and weight gains have been normal. None has shown clinical features suggesting persisting liver disease, except the patient who was followed for only 4 months who still has hepatomegaly. Serum albumin, prothrombin time, bilirubin, aspartate transaminase, and alkaline phosphatase all returned to normal but, in some instances, this was not until 24 months after the onset of the illness. All have remained normal on more-prolonged follow-up (Table 3) . 
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Liver biopsies were obtained within 4 months of the onset of the illness in 6 patients. All showed evidence of recent severe parenchymal necrosis with, in three instances, bridging collapse joining adjacent portal tracts and hepatic vein tributaries. In one child (Case 26) there was sufficient distortion of hepatic architecture to raise the suspicion of cirrhosis (Fig. 1) . Biopsies from 5 showed enough portal and periportal inflammatory activity to suggest a diagnosis of chronic aggressive hepatitis, while in Case 31 the features were those of a resolving hepatitis (Fig. 2) . Biopsies taken at least 8 months after the onset of the illness showed in 5 instances, postnecrotic scarring, 3 having persistent minimal infiltrate with inflammatory cells. Only 2 biopsies were considered normal. Liver biopsy was not performed in the survivor of the paracetamol overdose as hepatic recovery in such cases is usually complete."
Discussion
The mortality in children with fulminant hepatic failure in this series was 72%, increasing to 94% in those who developed grade 4 coma. These observations are similar to those reported by Saunders et al. 4 who found a mortality of 65 % in children in grade 3 coma, but a mortality of 85% in those in grade 4 coma. During the period of this study survival rates in adults with fulminant hepatic failure admitted to our unit ranged from 15 % (for those treated conservatively in the earlier years) to 30-38% (for those treated with charcoal haemoperfusion or by haemodialysis more recently).'2 In contrast to the findings of the Boston Fulminant Hepatic Failure Surveillance Study3 in which the mortality in fulminant hepatic failure in children of less than 14 years was 73%, compared with 80-97 % in adults, our study suggests that any lessening of fulminant hepatic failure in childhood is at best only marginal and does not extend to those with grade 4 encephalopathy.
No clinical features early in the illness could be correlated with survival nor were laboratory investigations helpful in indicating prognosis in the individual case. The outcome did not correlate with the duration of symptoms before the onset of the encephalopathy nor did they correlate with the duration of the encephalopathy itself.
In all survivors prolongation of the prothrombin time was less than 90 seconds, whereas this was so in only 12 of 20 fatal cases. Serum bicarbonate levels deviated above the normal range more often and to a greater extent in fatal cases than in survivors, and low values were more common in survivors. This 2-directional shift in serum bicarbonate values reflects the complexity of the metabolic changes which occur in fulminant hepatic failure. Record et al.13 showed that hyperventilation with respiratory alkalosis, metabolic alkalosis, and rarely, metabolic acidosis occur in the absence of renal failure.
A fatal outcome was often associated with at least one major complication. This study stresses the importance of the severity of the encephalopathy and the occurrence of other neurological complications in prognosis. Only one child in grade 4 coma for more than 24 hours survived. There were no survivors in those who developed generalised convulsions, myoclonic jerks, clinical evidence of brain stem dysfunction, or in those who required mechanical ventilation for persistent apnoea. The cause of the encephalopathy and the mechanism of brain swelling or cerebral oedema remain poorly understood. It is uncertain whether cerebral oedema is a toxic or metabolic effect acting directly on cerebral cell membranes, or whether it arises because of increased vascular permeability or hypo-osmolar extracellular fluid.22
Intravenous dexamethasone as used in this study did not prevent cerebral oedema although it has been shown to be of prophylactic value if used early in an experimental animal model of fulminant hepatic failure.'4 Papilloedema was not evident in any case in this series and thus its absence does not exclude serious brain swelling. Rational treatment to control cerebral oedema can only be evaluated by direct measurement of the intracranial pressure, preferably by an extradural pressure monitor. Such devices have given valuable information in the management of Reye's syndrome.15
Overt intestinal bleeding (which took place in 14 of 22 fatal cases), the development of renal failure (10 cases), and significant secondary bacterial or fungal infections (6 cases), were factors which were considered to have contributed to the fatal outcome, although in some patients it was often difficult to identify the precise cause of death. Saunders et al.4 reported a 70 % incidence of life-threatening haemorrhage in children. Prevention of alimentary bleeding must be a major aim in management, either by the use of prophylactic cimetidine'6 or by transfusions of fresh frozen plasma, platelets, or fresh whole blood, depending on the circumstances. The prevention and early treatment both of sepsis and renal failure must be major goals in management. The high incidence of respiratory complications in these children possibly results from a combination of the effects of pulmonary oedema (found in 35 % of adults)'7 and coma.
Early biopsies in 5 survivors showed the histological appearances of aggressive hepatitis, and subsequently in 5 instances postnecrotic scarring was found. In only 2 instances were the follow-up liver biopsy appearances normal. The frequency of this persistent histological abnormality after fulminant hepatic failure was unexpected and should be compared with the findings in adult patients in at least 90% of whom there is rapid complete histological recovery, 18 except in hepatitis B surface antigen-positive cases. 6 In this series of children with fulminant hepatic failure, the clinical and pathological features, and the complications, are similar to those observed in adults with this syndrome. The principles of management should therefore be similar. For recovery to occur in fulninant hepatic failure the encephalopathy must be reversible and the liver capable of regeneration. The difficulties in assessing the former have been mentioned. There is currently no way of assessing the latter in the individual patient, either by the early clinical course of the hepatitis or by special investigations, such as the serum alphafetoprotein level.1920
Maintaining physiological and biochemical homeostasis by intensive monitoring and supportive care, and the early identification and treatment of complications in units familiar with the many complex problems found in fulminant hepatic failure may reduce the mortality. If temporary liver support treatment, such as haemodialysis using a polyacrylonitrile membrane which has given encouraging results in 2 recent series,12 21 iS to influence survival, this must be introduced before grade 4 coma is established.
